Fact CheckerSign in

NCT07837349Not yet recruiting

Evaluation of the Clinical Value of NT-proBNP (or BNP) Measurement, Alone or in Combination With the EPOF Questionnaire, for the Screening of Chronic Heart Failure (CHF) in Adults Aged 40 Years and Older Referred for a Cardiology Consultation Without Suspected CHF.

Source: ClinicalTrials.gov · Last updated 23 Sept 2026

Brief summary (registry, in English)

This observational study aims to evaluate whether measuring NT-proBNP (or BNP), either on its own or alongside the EPOF questionnaire, can improve the early detection of chronic heart failure (CHF) in adults aged 40 years or over who are referred for an outpatient cardiology evaluation and have no known or suspected CHF. The study will address the following questions: Does systematic NT-proBNP (or BNP) testing help to identify previously unrecognised CHF? Does combining NT-proBNP (or BNP) with the EPOF questionnaire enhance diagnostic accuracy compared with using each tool alone? Participants will attend their routine cardiology consultation, complete the EPOF questionnaire and undergo NT-proBNP (or BNP) testing as part of the clinical assessment. They will also allow the collection of relevant medical data. The diagnostic performance of these tools will then be compared with the final diagnosis made by the outpatient cardiologist. The study focuses on a population referred from primary care with increased cardiovascular risk. The early use of simple, accessible tools could reduce diagnostic delays, improve referral appropriateness and facilitate the earlier detection of CHF in general practice.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
1000 (estimated)
First submitted
7 Aug 2026
Start date
Sept 2026
Primary completion date
Apr 2027
Lead sponsor
French Cardiology Society
NCT number
NCT07837349

What you commit to

  • Study type: Observational
  • Planned participants: 1000
  • From Sept 2026 to the primary completion date, Apr 2027
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Known diagnosis of chronic heart failure (CHF).

Other

  • Refusal to participate.

Who the study is looking for

  • Adults aged 40 to 80 years.
  • Referred for a cardiology consultation for a reason other than suspected chronic heart failure or any of the four EPOF signs.
  • Informed about the study and not objecting to participation, in accordance with applicable regulations.

Age in the registry: 40 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Private Cardiology Practice
Coordinator of this site? Confirm its status
NîmesFranceUnknown status
Polyclinique de Poitiers - GCS ELSAN
Coordinator of this site? Confirm its status
PoitiersFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.